Real-World Analysis of Initial Clinical Response and Future Outcomes Among Patients with Rheumatoid Arthritis Initiating and Remaining on a First-Line Tumor Necrosis Factor Inhibitor in the United States
Rheumatol Ther. 2025 Nov 14. doi: 10.1007/s40744-025-00808-z. Online ahead of print. ABSTRACT INTRODUCTION: This study aimed to evaluate a subsequent […]
